Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
07 Mayo 2024 - 6:00AM
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage
biopharmaceutical company developing a pipeline of novel drug
candidates against validated molecular targets in indications of
high unmet medical need, today announced that it will participate
in a fireside chat at the 2024 RBC Capital Markets Global
Healthcare Conference on Tuesday, May 14, 2024 at 4:35 p.m. ET in
New York, New York.
A live webcast for this event will be accessible
on the Events page under the Investor Relations section of the
Applied Therapeutics website at www.appliedtherapeutics.com. A
replay of the webcast will be archived on the Company’s website for
90 days following the event.
About Applied Therapeutics
Applied Therapeutics is a clinical-stage
biopharmaceutical company developing a pipeline of novel drug
candidates against validated molecular targets in indications of
high unmet medical need. The Company’s lead drug candidate,
govorestat, is a novel central nervous system penetrant Aldose
Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic
diseases, including Galactosemia, SORD Deficiency, and PMM2-CDG.
The Company is also developing AT-001, a novel potent ARI, for the
treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of
the heart. The preclinical pipeline also includes AT-003, an ARI
designed to cross through the back of the eye when dosed orally,
for the treatment of Diabetic retinopathy.
To learn more, please visit
www.appliedtherapeutics.com and follow the company on Twitter
@Applied_Tx.
Contacts
Investors: Maeve Conneighton
(212) 600-1902 appliedtherapeutics@argotpartners.com
Media:media@appliedtherapeutics.com
Applied Therapeutics (NASDAQ:APLT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Applied Therapeutics (NASDAQ:APLT)
Gráfica de Acción Histórica
De May 2023 a May 2024